Review
doi: 10.1016/j.urology.2006.08.1107.
Nonurothelial cancer of the bladder
Affiliations
- PMID: 17280911
- DOI: 10.1016/j.urology.2006.08.1107
Item in Clipboard
Review
Nonurothelial cancer of the bladder
Urology.
2007 Jan.
Abstract
In this article, we review available evidence on the treatment of patients with nonurothelial cancer of the bladder. More than 150 published works were reviewed in preparation for this summary. Squamous cell carcinoma and adenocarcinoma are ideally treated with radical cystectomy. High-risk groups for these diseases are defined. Small cell carcinoma should be treated with multimodality therapy, including chemotherapy. Other rarer tumors of the bladder are also discussed.
Similar articles
-
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.Cancer. 2007 Aug 15;110(4):764-9. doi: 10.1002/cncr.22853. Cancer. 2007. PMID: 17614317
-
The impact of variant histology on the outcome of bladder cancer treated with curative intent.Urol Oncol. 2009 Jan-Feb;27(1):3-7. doi: 10.1016/j.urolonc.2007.07.010. Epub 2008 Jan 14. Urol Oncol. 2009. PMID: 18367107 Review.
-
Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.Am J Clin Oncol. 2009 Dec;32(6):592-606. doi: 10.1097/COC.0b013e318199fb42. Am J Clin Oncol. 2009. PMID: 19593084
-
Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.Eur J Surg Oncol. 2009 Apr;35(4):352-5. doi: 10.1016/j.ejso.2008.07.001. Epub 2008 Aug 22. Eur J Surg Oncol. 2009. PMID: 18722076
-
Multimodality bladder preservation therapy for muscle-invasive bladder tumors.Semin Oncol. 2007 Apr;34(2):129-34. doi: 10.1053/j.seminoncol.2006.12.009. Semin Oncol. 2007. PMID: 17382796 Review.
Cited by
-
Primary non-urothelial squamous cell carcinoma masquerading as a perforated gastric ulcer: a case report.J Surg Case Rep. 2019 Jul 23;2019(7):rjz216. doi: 10.1093/jscr/rjz216. eCollection 2019 Jul. J Surg Case Rep. 2019. PMID: 31360437 Free PMC article.
-
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.J Urol. 2012 Jan;187(1):74-9. doi: 10.1016/j.juro.2011.09.056. Epub 2011 Nov 16. J Urol. 2012. PMID: 22088332 Free PMC article.
-
Characteristics and clinical significance of histological variants of bladder cancer.Nat Rev Urol. 2017 Nov;14(11):651-668. doi: 10.1038/nrurol.2017.125. Epub 2017 Sep 12. Nat Rev Urol. 2017. PMID: 28895563 Review.
-
Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15. Mol Cancer Ther. 2017. PMID: 28619755 Free PMC article.
-
Bladder's Blind Spot: A Rare Case of Non-bilharzial Diverticular Squamous Cell Carcinoma Treated With Partial Cystectomy.Cureus. 2025 Mar 25;17(3):e81144. doi: 10.7759/cureus.81144. eCollection 2025 Mar. Cureus. 2025. PMID: 40276459 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
